Skip to main content

Advertisement

SpringerLink
Log in

Plasminogen activators and their inhibitor gene expression in cutaneous NF1-related neurofibromas

  • Short Communication
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Cutaneous neurofibromatosis 1 (NF1)-related neurofibromas are benign tumors and composed of Schwann cells, perineurial cells and/or fibroblasts, endothelial cells, mast cells and macrophages. Extracellular proteolysis namely plasminogen activation (PA) operates in many tissue destructive processes. We wanted to study plasminogen activators, urokinase (uPA) and tissue type (tPA) and their inhibitor PAI-1, which have not earlier been studied comprehensively in cutaneous NF1-related tumors. We analyzed the distribution of uPA, tPA and PAI-1 antigen level by immunohistochemistry and mRNA level by in situ hybridization, to identify which cells are primarily involved in proteolytic activity and plasminogen activation. Twelve NF1 skin tumor samples from six patients were obtained during the operations. Mast cells, macrophages and endothelial cells were distributed only locally. Their expression levels of PA components were not so notable. Large extent of tumor cells of Schwann cell origin and prominent expression levels of uPA, tPA and PAI-1 indicated that these cells are responsible for the main source of PA components in cutaneous NF1-related neurofibromas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Clark MB, Zeheb R, White TK, Bunge RP (1991) Schwann cell plasminogen activator is regulated by neurons. Glia 4:514–528

    Article  PubMed  CAS  Google Scholar 

  2. Collen D (1979) On the regulation of fibrinolysis. Thromb Haemost 43:77–89

    Google Scholar 

  3. Declerck PJ, De Mal M, Alessi M-C, Baudner S, Paques EP, Preissner KT, Muller-Berghaus G, Collen D (1988) Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 263:15454–15461

    PubMed  CAS  Google Scholar 

  4. Evans GR, Scheithauer B, Komminoth P, Peltonen J (2004) Neurofibromatosis 1. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumours. Pathology and Genetics: tumours of endocrine organs, Chap 5. Inherited tumour syndromes. IARCPress, Lyon, pp 243–248

  5. Ferrier CM, Suciu S, van Geloof WL, Straatman H, Eggermont AM, Koops HS, Kroon BB, Lejeune FJ, Kleeberg UR, van Muijen GN, Ruiter DJ (2000) High tPA-expression in primary melanoma of the limb correlates with good prognosis. Br J Cancer 83:1351–1359

    Article  PubMed  CAS  Google Scholar 

  6. Myöhänen H, Vaheri A (2004) Regulation and interactions in the activation of cell-associated plasminogen. Cell Mol Life Sci 61:1–19

    Article  PubMed  CAS  Google Scholar 

  7. Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J (1988) Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest 59:760–771

    PubMed  CAS  Google Scholar 

  8. Rogister B, Delree P, Leprince P, Martin D, Sadzot C, Malgrange B, Munaut C, Rigo JM, Lefebyre PP, Octave JN (1993) Transforming growth factor beta as a neuronoglial signal during peripheral nervous system response to injury. J Neurosci Res 34:32–43

    Article  PubMed  CAS  Google Scholar 

  9. Salonen E-M, Vaheri A, Pöllänen J, Stephens RW, Andreasen PA, Mayer M, Danø K, Gailit J, Ruoslahti E (1989) Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J Biol Chem 264:6339–6343

    PubMed  CAS  Google Scholar 

  10. Sawaya R, Rämö J, Shi ML, Mandybur G (1991) Biological significant of tissue plasminogen activator content in brain tumors. J Neurosurg 74:480–486

    Article  PubMed  CAS  Google Scholar 

  11. Sillaber C, Baghestanian M, Bevec D, Willheim M, Agis H, Kapiotis S, Fureder W, Bankl HC, Kiener HP, Speiser W, Binder BR, Lechner K, Valent P (1999) The mast cell as site of tissue-type plasminogen activator expression and fibrinolysis. J Immunol 162(2):1032–1041

    PubMed  CAS  Google Scholar 

  12. Sirén V, Antinheimo J-P, Jääskeläinen J, Böhling T, Carpén O, Vaheri A (2004) Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas. Acta Neurochir 146:111–118

    Article  Google Scholar 

  13. Teesalu T, Kulla A, Simisker A, Sirén V, Lawrence DA, Vaheri A (2004) Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost 92:358–368

    PubMed  CAS  Google Scholar 

  14. Yamashita J, Ogawa M, Yamashita S, Nakashima T, Saishoji T, Nomura K, Inada K, Kawana I (1993) Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer. Br J Cancer 68:524–529

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from Finnish Cancer Societies.

Author information

Authors and Affiliations

  1. Haartman Institute, University of Helsinki, P.O. Box 21, 00014, Helsinki, Finland

    Vappu Sirén & Antti Vaheri

  2. Department of Medical Biochemistry/Anatomy, University of Turku, Kiinanmyllynkatu 10, 20520, Turku, Finland

    Juha Peltonen

Authors
  1. Vappu Sirén
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juha Peltonen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antti Vaheri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vappu Sirén.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sirén, V., Peltonen, J. & Vaheri, A. Plasminogen activators and their inhibitor gene expression in cutaneous NF1-related neurofibromas. Arch Dermatol Res 297, 421–424 (2006). https://doi.org/10.1007/s00403-005-0637-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-005-0637-x

Keywords

Search

Navigation